Track 6: Glaucoma: Visual field loss

Glaucoma is a multifactorial optic neuropathy that affects more than 50 million people and is the second leading cause of blindness worldwide. The role of intra ocular pressure (IOP) has been well documented as a major modifiable risk factor for glaucoma. Additionally, many glaucoma patients have a relatively low IOP, while some healthy individuals have a relatively high IOP. The disorders can be roughly divided into two main categories, open-angle glaucoma and closed-angle glaucoma. Impaired ocular blood flow regulation in open angle glaucoma as a risk of glaucoma has also been well established, especially over the past two decades. Pathophysiology of glaucoma indicates towards the increased in intraocular pressure which compresses and damages the optic nerve. Once the optic nerve is damaged, it fails to carry visual information to the brain and this result in loss of vision. The exact pathophysiology of glaucoma contributing to this is yet to be determined. Biomarkers for glaucoma have predictive use that could help and guide more specific therapy in some glaucoma patients. Endothelin in glaucoma treatment play a very key role in pathogenesis of glaucoma. Glaucoma accounts for over 10 million visits to physicians each year. In terms of Social Security benefits, lost income tax revenues, and health care expenditures, the cost to the U.S. government is estimated to be over $1.5 billion annually. The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than two million dollars in support of 150 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada. Bascom Palmer and Wills Eye are the top researcher organization for glaucoma.7 Entrepreneurs Investment meet

 

  • Pathophysiology of Glaucoma
  • Open-angle Glaucoma
  • Biomarkers for Glaucoma
  • Endothelin in Glaucoma treatment
  • Complications and Management of Glaucoma Filtering
  • Closed-angle Glaucoma

Related Conference of Track 6: Glaucoma: Visual field loss

February 02-03, 2023

6th International Eye and Vision Congress

Barcelona, Spain
February 20-21, 2023

4th International Conference on Ear Nose & Throat

Singapore City, Singapore
April 20-21, 2023

8th International Conference on Eye and Vision

Paris, France
May 17-18, 2023

23rd Global Ophthalmologists Annual Meeting

Prague, Czech Republic
May 24-25, 2023

3rd International Conference on Optics & Photonics

Montreal, Canada
May 31-01, 2023

9th Global Ophthalmology Meeting

Rome, Italy
July 26-27, 2023

17th International Conference on Hepatology

Singapore City, Singapore
July 31-01, 2023

37th European Ophthalmology Congress

Vancouver, Canada
August 28-29, 2023

22nd Asia Pacific Ophthalmologists Annual Meeting

Tokyo, Japan
September 18-19, 2023

33rd International Congress on Vision Science and Eye

Rome, Italy
October 02-03, 2023

33rd World Congress on Ophthalmology and Optometry

Frankfurt, Germany
October 09-10, 2023

4th International Conference on Optometry

Prague, Czech Republic
November 06-07, 2023

7th World Congress on Eye and Vision

Stockholm, Sweden

Track 6: Glaucoma: Visual field loss Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in